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Abstract  
Nerve growth factor plays a key role in the initiation as well as the prolonged heightened pain 
sensitivity of the inflammatory response.  Previously, we showed that NGF rapidly augmented 
both the excitability of isolated rat sensory neurons and the mechanical sensitivity of the rat’s 
hind paw.  The increase in excitability and sensitivity were blocked by the myristolated 
pseudosubstrate inhibitor of atypical PKCs (mPSI), suggesting that an atypical PKC may play a 
key regulatory role in generating this heightened sensitivity.  Our findings raised the question as 
to whether NGF directs changes in translational control, as suggested for long-lasting LTP, or 
whether NGF leads to the activation of an atypical PKC by other mechanisms.  The current 
studies demonstrate that enhanced action potential firing produced by NGF was blocked by 
inhibitors of translation, but not transcription.  In parallel, in vitro studies showed that NGF 
elevated the protein levels of PKMζ, which was also prevented by inhibitors of translation.  
Intraplantar injection of NGF in the rat hind paw produced a rapid and maintained increase in 
mechanical sensitivity whose onset was delayed by translation inhibitors.  Established NGF-
induced hypersensitivity could be transiently reversed by injection of rapamycin or mPSI.  These 
results suggest that NGF produces a rapid increase in the synthesis of PKMζ protein in the paw 
that augments neuronal sensitivity and that the ongoing translational expression of PKMζ plays 
a critical role in generating as well as maintaining the heightened sensitivity produced by NGF.   
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Highlights: 
 NGF produced a significant time-dependent increase in the number of APs, which was 
blocked by inhibitors of translation, but not transcription 
 
 NGF increased the levels of PKMζ protein that was blocked by inhibitors of translation 
 
 
 Injection of NGF produced a hindpaw mechanical hypersensitivity whose onset was 
delayed by inhibitors of translation 
 
 Established mechanical hypersensitivity produced by NGF could be reversed by either 
rapamycin or mPSI 
 
 
Keywords:  sensory neuron; sensitization; neurotrophin; protein synthesis; excitability; 
hyperalgesia 
 
Abbreviations: APs, action potentials; CFA, complete Freund’s adjuvant; DRG, dorsal root 
ganglion; HPRT, hypoxanthine-guanine phosphoribosyltransferase; LTP, long-term potentiation; 
MPE, maximal possible effect; mPSI, myristolated pseudosubstrate inhibitor of atypical PKCs; 
NGF, nerve growth factor; RE, response efficiency; VFH, von Frey hair; ZIP, zeta inhibitory 
peptide 
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Introduction 
Neurotrophins, such as nerve growth factor (NGF), play key roles in the initiation of the 
inflammatory response by their ability to activate or traffic a variety of immune cells to a site of 
injury (Levi-Montalcini et al., 1996; Skaper, 2001; Villoslada and Genain, 2004; Nockher and 
Renz, 2006; Linker et al., 2009; Seidel et al., 2010).  An early study demonstrated that the levels 
of NGF were elevated in blister exudates obtained from the hindpaw skin of rats (Weskamp and 
Otten, 1987).  Additionally, application of NGF was shown to lead to the release of histamine 
(Bruni et al., 1982; Mazurek et al., 1986) and serotonin (Horigome et al., 1993) from rat 
peritoneal mast cells.  NGF was proven to be chemotactic for human (Gee et al., 1983) and 
mouse (Boyle et al., 1985) polymorphonuclear leukocytes.  Human B cells express the TrkA 
receptor for NGF (Otten et al., 1989; Brodie and Gelfand, 1992) and their proliferation was 
augmented upon exposure to NGF (Otten et al., 1989; Brodie and Gelfand, 1992; Thorpe and 
Perez-Polo, 1987).  Finally, immune-competent cells, such as mouse CD4+ and CD8+ T 
lymphocytes (Ehrhard et al., 1993; Santambrogio et al., 1994) and rat peritoneal mast cells 
(Leon et al., 1994), express the mRNA for NGF as well release biologically active NGF upon 
activation.   
 
In this capacity, NGF can also enhance the sensitivity of nociceptive sensory neurons to 
different modalities of stimulation and thereby lead to heightened pain states (reviewed by 
McMahon, 1996; Woolf, 1996).  Intraperitoneal injection of NGF was reported to greatly 
enhance the sensitivity to both mechanical and thermal stimulation of the hindpaw of a rat 
(Lewin et al., 1993).  Intraplantar injection of complete Freund’s adjuvant (CFA) also augments 
the hindpaw sensitivity to mechanical or thermal stimulation; this CFA-induced hypersensitivity 
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was blocked by injection of an antibody to NGF, indicating that elevated NGF directly mediates 
this inflammatory pain (Woolf et al., 1994; Lewin et al., 1994; Nicol and Vasko, 2007).   
 
The hypersensitivity of nociceptive sensory neurons after exposure to inflammatory mediators 
has, in some ways, been likened to the effects of agonist- or high frequency-stimulation of nerve  
fibers in the hippocampus that result in long-term potentiation (LTP).  The long-lasting or 
maintenance phase of LTP depends on the synthesis of new proteins (Stanton and Sarvey, 
1984; Kelleher et al., 2004; Costa-Mattioli et al., 2009) wherein one key protein associated with 
LTP is the atypical PKC known as PKMζ (Sacktor et al., 1993; Sacktor, 2011).  PKMζ can be 
expressed from an internal promoter within the full length PKCζ gene, resulting in a truncated 
product that lacks the regulatory domain, rendering this product constitutively active (Hernandez 
et al., 2003).  Several different studies suggested that this variant plays a key role in the 
maintenance of long-term synaptic strength.  For example, treatment with the myristolated 
pseudosubstrate inhibitor (mPSI) of atypical PKCs reversed established LTP (Ling et al., 2002).  
In an in vivo study of conditioned taste aversion (CTA) as an animal model of memory, infusion 
of mPSI into the insular cortex suppressed the CTA memory (Shema et al., 2007).  Finally, lenti-
viral over-expression of PKMζ enhanced CTA memory, whereas introduction of a dominant-
negative PKMζ led to suppression (Shema et al., 2011).   
 
Our previous studies demonstrated that treatment with NGF acutely enhanced the excitability of 
isolated rat sensory neurons (Zhang et al., 2002; Zhang et al., 2012) and that intraplantar 
injection of NGF produced a significant hypersensitivity to mechanical and thermal stimulation of 
the rat’s hindpaw (Khodorova et al., 2013, 2017).  The NGF-induced augmentation of 
excitability, mechanical, and thermal sensitivity were blocked by pretreatment with mPSI.  In 
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addition, siRNA targeted to PKCζ significantly reduced the expression of PKMζ, but not that of 
either PKCζ or PKCλ/ι, and blocked the NGF-mediated increases in the excitability of sensory 
neurons (Zhang et al., 2012).  These observations indicate that PKMζ plays a key regulatory 
role in generating the heightened sensitivity resulting from exposure to NGF.  Our findings then 
suggest two possible explanations: NGF engages the translational control pathway, as has 
been suggested for long-lasting LTP in the central nervous system, or by some other 
mechanisms NGF leads to the activation of an atypical PKC in the peripheral nervous system. 
 
Experimental Procedures 
Isolation and Maintenance of Sensory Neurons 
Sensory neurons were harvested from young adult Sprague-Dawley rats (80-150 g) (Harlan 
Laboratories, Indianapolis, IN, USA).  Briefly, male rats were killed by placing them in a 
chamber that was then filled with CO2.  Dorsal root ganglia (DRG) were isolated and collected in 
a conical tube with sterilized Puck’s solution.  The tube was centrifuged for 1 min at 
approximately 2000 x g and the pellet was resuspended in 1 ml Puck’s solution containing 10 U 
of papain (Worthington, Lakewood, NJ, USA).  After 15 min incubation at 37°C, the tube was 
centrifuged at 2000 x g for 1 min and the supernatant was replaced by 1 ml F-12 medium 
containing 1 mg collagenase IA and 2.5 mg dispase II (Roche Diagnostics, Indianapolis, IN, 
USA).  The DRGs were resuspended and incubated at 37°C for 20 min.  The suspension was 
centrifuged for 1 min at 2000 x g and the supernatant was removed.  The pellet was 
resuspended in F-12 medium supplemented with 10% heat-inactivated horse serum and 30 
ng/ml NGF (Harlan Bioproducts, Indianapolis, IN, USA) and mechanically dissociated with fire-
polished glass pipette until all visible chunks of tissue disappeared.  Isolated cells were plated 
onto either plastic coverslips (electrophysiology experiments) or 6-well tissue culture plates 
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(Western blotting experiments); both surfaces were previously coated with 100 μg/ml poly-D-
lysine and 5 μg/ml laminin.  Cells were then maintained in culture in an F-12 medium 
supplemented with 30 ng/ml NGF at 37°C and 3% CO2 for either 18-24 h before 
electrophysiological recording or for 48 h before administering treatments and collecting cell 
lysates for Western blotting experiments.  All procedures were approved by the Animal Use and 
Care Committee of the Indiana University School of Medicine.  
  
Electrophysiology  
Recordings were made using the whole-cell patch-clamp technique as previously described 
(Zhang et al., 2012).  Briefly, a coverslip with sensory neurons was placed into a culture dish 
containing normal Ringer’s solution of the following composition (in mM): 140 NaCl, 5 KCl, 2 
CaCl2, 1 MgCl2, 10 HEPES and 10 glucose, with pH adjusted to 7.4 using NaOH; after 
approximately 15 min, the cover slip was transferred to the recording chamber filled with 
Ringer’s solution.  Recording pipettes were pulled from borosilicate glass tubing (Model 
G85165T-4, Warner Instruments, Hamden, CT, USA).  Recording pipettes had resistances of 2-
5 MΩ when filled with the following solution (in mM): 140 KCl, 5 MgCl2, 4 ATP, 0.3 GTP, 0.25 
CaCl2, 0.5 EGTA, (calculated free Ca
2+
 concentration of 100 nM, MaxChelator), and 10 HEPES, 
at pH 7.2 adjusted with KOH.  Whole-cell voltages were recorded with an Axopatch 200 or 
Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA, USA).  Data were acquired and 
analyzed with pCLAMP 10 (Molecular Devices).  All drugs were applied with a VC-8 bath 
perfusion system (Warner Instruments).  NGF was used at a concentration of 100 ng/ml, which 
was based on the observation that this concentration produced a significant sensitization of the 
capsaicin-gated current in small-diameter rat sensory neurons (Shu and Mendell, 1999).  In the 
current clamp experiments, the neurons were held at their resting potentials (between −45 and 
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−65 mV) and a depolarizing current ramp (1000 ms in duration) was applied.  The amplitude of 
a ramp was adjusted to produce between 2 and 4 action potentials (APs) under control 
conditions for each individual neuron and then that same ramp was used throughout the 
recording period for that particular neuron.  Voltages were filtered at 5 kHz and sampled at 2 
kHz.  At the end of each recording, the neuron was exposed to 400 nM capsaicin.  This 
neurotoxin was used to distinguish capsaicin-sensitive sensory neurons as these neurons are 
believed to transmit nociceptive information (Holzer, 1991).  However, the correlation between 
capsaicin sensitivity and neuronal identity as a nociceptor is not absolute; some nociceptive 
neurons are insensitive to capsaicin and some capsaicin-sensitive neurons are not nociceptors 
(Petruska et al., 2000).  Therefore, this agent was used to define a population of small-diameter 
sensory neurons that could serve a nociceptive function.  All results presented in this report 
were obtained from capsaicin-sensitive neurons, unless otherwise stated.  All experiments were 
performed at room temperature, ~23°C. 
 
Western Blot 
After 48 h in culture, the medium was removed from the DRG cells, each well was washed with 
1 ml  PBS (37°C), and then 1 ml of F12 medium with no additional NGF was added to each well 
for 15 min at 37°C in 3% CO2.  Either vehicle or a final concentration of 50 μg/ml cycloheximide 
was then added to the culture medium and the cells were incubated for an additional 60 min.  At 
this point, vehicle (100 μl F12 medium, no NGF) or NGF (100 μl of 1 ng/μl NGF in F12 medium) 
was added to the appropriate wells and the cells were returned to the incubator for 30 min.  The 
culture medium was then removed from the cells, the plates were placed on ice, and each well 
was then washed twice with 1 ml ice-cold PBS.  Cells were lysed with 150 μl per well of ice-cold 
RIPA lysis buffer (catalog #20-188, Millipore Corp., Billerica, MA) containing a 100-fold dilution 
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of Protease Inhibitor Cocktail Set III (catalog #539134, EMD Biosciences, San Diego, CA) and 
phosphatase inhibitors (1 mM sodium fluoride, 1 mM activated sodium orthovanidate).  Cells 
were scraped from the wells, lysates were collected into 1.5 ml tubes, and the lysates were 
sonicated (Fisher Scientific Sonic Dismembrator 550, setting 3, 2 pulses, 1 sec each pulse).  
Cell debris was removed by centrifugation at 2500 x g for 5 min at 4°C.  Supernatants were 
transferred to fresh tubes.  The total protein concentrations in the lysates were measured using 
the Bradford Method (catalog #500-0006, Protein Assay Dye Reagent, Bio-Rad Laboratories, 
Hercules, CA). 
 
Equivalent amounts of reduced, denatured protein (20 µg) were separated by electrophoresis in 
a NuPAGE® 4-12% Bis-Tris gel (catalog #NP0335BOX, Invitrogen, Carlsbad, CA) using 
NuPAGE® MES-SDS running buffer (catalog #NP0002, Invitrogen).  The separated proteins 
were then transferred from the gel to an Invitrolon PVDF membrane (catalog #LC2005, 
Invitrogen).  The membranes were blocked with 1X TBS containing 5% (w/v) non-fat dry milk for 
1 h at room temperature, with agitation.  To measure atypical PKC (aPKC) expression levels, a 
polyclonal rabbit antibody that recognizes PKCζ, PKMζ, and PKCλ/ι (sc-216, 1:500, Santa Cruz 
Biotechnology Inc., Santa Cruz, CA) was incubated in 1X TBS, 0.1% (v/v)Tween 20 and 1% 
(w/v) non-fat dry milk for 18 hs at 4°C with agitation.  These protein isoforms were 
distinguishable based on differences in their molecular weights.  Reference protein expression 
was determined using rabbit polyclonal antibody to HPRT (sc-20975, 1:500, Santa Cruz 
Biotechnology Inc., Santa Cruz, CA) and mouse monoclonal antibody to actin (catalog #MA5-
11869, ACTN05, C4, 1:2500, Thermo Scientific, Rockford, IL).  After primary antibody 
incubation, membranes were washed (3 x 10 min) with 1X TBS containing 0.1% (v/v) Tween 20, 
at room temperature, with agitation.  The membranes were then incubated with horseradish 
peroxidase-labeled goat anti-rabbit secondary antibody (sc-2004, 1:2500, Santa Cruz 
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Biotechnology Inc., Santa Cruz, CA) in TBS-Tween-milk for 1.5 h at room temperature, with 
agitation.  After washing, immunoreactive bands on the membranes were developed by 
SuperSignal™ West Dura Extended Duration Substrate (catalog #34076, Thermo Scientific, 
Rockford, IL) and visualized by exposure to CL-X Posure™ film.  The film was photographed 
with a Kodak DC290 CCD camera and the density of each band was measured using Kodak 1D 
3.6 software (Kodak Scientific Imaging Systems, New Haven, CT). The summary data are 
expressed as the density of the experimental bands normalized to the density of their respective 
HPRT bands.  Three independent experiments were conducted for statistical analysis. 
 
Behavioral Measurements of Mechanical Sensitivity 
Experiments were conducted on a total of 65 adult male Sprague-Dawley rats (240-300 g).  
Rats were housed in groups of two per cage under a 12:12 h dark:light cycle and were provided 
with food and water ad libitum.  Animals were experimentally treated and cared for in 
accordance with the Guide for the Care and Use of Laboratory Animals (Guide, 2011), using 
protocols as reviewed and approved by the Harvard Committee on Animals.  Unrestrained rats 
were placed on an elevated plastic mesh floor (28 x 17.5 cm; 9.5 x 9.5 mm openings) and 
allowed to habituate for 25-40 min before initial testing. Paw Withdrawal Frequency to 
mechanical stimulation was determined using a 10 or 15 g calibrated von Frey hair (VFH) 
applied perpendicularly to the plantar surface of the hind paw through the spacing in the mesh 
floor.  The VFH was applied 10 times, each for 3 sec maximum, or until paw withdrawal.  To 
minimize stress and to obtain consistent responsiveness to the force, the rats were habituated 
and tested on these same mesh racks over 5-6 days before any test substances were injected 
(training period).  Four rats were tested together in any single test session.  Each rat in any 
single session received the same treatment, and the tester was not blinded to the treatment.  
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Withdrawal responses were registered initially on the ipsilateral (NGF-injected) paw and then on 
the contralateral paw.  The number of paw withdrawals, n, occurring in response to a total of 10 
stimuli with any single VFH force was used to assess mechanical sensitivity, and reported as 
the “Response Efficiency” (RE). 
 
In experiments designed to test the preventive activity of translational inhibitors, cycloheximide 
(n=11), rapamycin (n=12), or their respective vehicle (n=6, for each group, n=12 total), alone or 
with NGF, were injected subcutaneously (s.c.) in a 10 μl volume (with 4 μg NGF injected in 20 
μl), into the mid-plantar hind paw, 1 cm distal from the heel.  Injections were performed under 
brief general anesthesia from inhalation of the rapidly reversible agent sevoflurane (Abbott 
Labs, N. Chicago, IL, USA).  After anesthesia was discontinued, the righting reflex recovered in 
<30 sec; 5-10 min later “normal” baseline nocifensive responses could be assessed.  To test the 
ability of specific protein synthesis inhibitors to prevent the development of NGF-induced 
hyperalgesia, the following injection protocols were used.  The first injection of cycloheximide 
occurred 1 h prior to the NGF injection, and the second injection was mixed with NGF.  
Rapamycin was injected once, 0.5 h prior to NGF with concentrations and doses indicated in the 
Results and figure legends.  In control experiments, NGF was injected 1 h after the injection of 
the vehicle used for cycloheximide (PBS, 10 μl), or 0.5 h after the injection of the vehicle used 
for rapamycin (DMSO, 10 μl).  In experiments intended to reverse an established, long-lasting 
hyperalgesia, rapamycin (10 μl, n=9) or vehicle, (DMSO, 10 μl, n=8) was injected 3 days after 
paw injection of 3-5 μg of NGF.  The role of aPKCs in NGF-induced hypersensitivity was tested 
by intraplantar injection of  mPSI (40 μg, 20 μl, n=11) or its inactive, scrambled analogue, (scr-
mPSI, n=8) 3 days after 4 μg of NGF. 
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Data Analysis- In vitro experiments 
Results are presented as the means ± standard error of the mean (SEM).  Statistical differences 
between the controls and those obtained under various treatment conditions were determined 
by either an ANOVA or a repeated measures (RM) ANOVA when appropriate. When a 
significant difference was obtained, post hoc analyses were performed using a Holm-Sidak all-
pairs test; the degrees of freedom (df) and the sum of squares (ss) are reported.  If the data set 
failed the normality test, either a Kruskal-Wallis one-way ANOVA on ranks was performed, 
followed by a Tukey or a Dunn’s all pairwise test yielding an H value and the df or a Friedman 
repeated measures ANOVA followed by a Tukey all pairwise test yielding a Chi square value Χ
2
 
and the df.  The df and H or Χ
2
 are reported.  Results were considered statistically significant 
when P≤0.05 (SigmaStat 3.5 Software). 
 
In vivo experiments 
Behavioral results are graphically presented as medians ± 25th  and 75th percentile (boxplot) and  
10th  and 90th percentiles (whiskers).  Statistical analysis applied Kruskal-Wallis tests followed by 
Wilcoxon Rank Sum tests for pairwise comparisons.  Analyses  by Kruskal-Wallis are reported 
with the value of H, degrees of freedom (df), and probability of significance (P) values for all the 
groups being compared; pair-wise comparisons by the Wilcoxon Rank Sum test, are reported as 
the number of samples in the compared groups and the exact P values.  Two comparisons were 
made: 1. Response Efficiency after injections of NGF compared to Response Efficiency during 
the Baseline, pre-injection period, for the different translational inhibitor tests of prevention.  2. 
Comparisons, at the same time point, of Response Efficiency in vehicle-injected rats with those 
of inhibitor-injected rats.  The effectiveness of an inhibitor to reverse existing hypersensitivity 
was quantified as follows; the increase in paw response efficiency on post-NGF day 3 (D3) 
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compared to baseline was defined as Maximum Possible Effect (MPE) of NGF.  Suppression of 
RE by the inhibitors on day X after NGF injection (DX) was expressed as %MPE, where %MPE 
= [(RE@DX – RE@D3) / (RE@D3 – baseline RE)] x 100. 
 
Chemicals- In vitro experiments 
F-12 Nutrient Mixture (catalog #21700-075, Gibco) was supplemented with the following per 
liter: 1.18 g NaHCO3 (catalog #S6014, Sigma), 1X (2 mM) L-glutamine (catalog #25030-081, 
Gibco), 50 units penicillin-50 mg/ml streptomycin (catalog #15070-063, Gibco), 10% heat-
inactivated horse serum (catalog #26050-088, Gibco), 9 μg/ml 5-fluoro-2'-deoyuridine (catalog 
#F-0503, Sigma), and 21 μg/ml uridine (catalog #U-3750, Sigma).  All other chemicals were 
obtained from Sigma-Aldrich (St. Louis, MO, USA).  Actinomycin D and 4EGI-1 were dissolved 
in DMSO.  Capsaicin, cycloheximide, and rapamycin were dissolved in 1-methyl-2-pyrrolidinone 
(MPL). The MPL stock solutions were then diluted with Ringer’s solution to yield the appropriate 
concentrations. The vehicle, MPL was typically used at 1,000- to 5,000-fold dilutions.  Our 
earlier studies demonstrated that MPL does not affect the potassium or sodium currents in the 
DRG sensory neurons (Zhang et al., 2002). 
 
 In vivo experiments 
NGF-β (rat) (Sigma-Aldrich, St. Louis MO, USA, or [556-NG-100/CF] R&D Systems, 
Minneapolis MN, USA) was made as a stock solution (100 ng/μl or 200 ng/μl in Ca
2+ + Mg
2+ free 
PBS, pH 7.4) and stored in 40 μl aliquots at –80°C.  Prior to the injection, NGF stock aliquots 
were diluted (1:1) in PBS or mixed with the cycloheximide stock solution (for co-injections) to the 
indicated final concentration of 50-200 ng/μl.  Cycloheximide (Sigma-Aldrich, St. Louis MO, 
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USA) was dissolved in PBS as a 20 mM stock solution and stored in 40 μl aliquots at –80°C; 
stock aliquots of cycloheximide were then diluted (1:1) in PBS.  Rapamycin (Enzo Life Sciences, 
Farmingdale, NY) was dissolved in DMSO as a 20 mM  stock solution, stored in aliquots at –80° 
C, and then diluted to 10 mM in DMSO before hind paw injection.  The atypical PKC 
pseudosubstrate inhibitor, mPSI (Enzo Life Sciences) was dissolved first in dH2O to 10 μg/μl, 
then diluted 1:5 in PBS and stored in 100 μl aliquots at −80°C.  The same procedure was used 
for the scrambled pseudosubstrate inhibitor, a control substance for mPSI (Tocris/R&D 
Systems, Minneapolis, MN). 
 
RESULTS  
Inhibitors of translation, but not transcription, block the NGF-induced increase in excitability 
Our previous studies demonstrated that both the NGF-mediated increase in excitability of 
sensory neurons and behaviorally assessed mechano- and thermal hypersensitivity were linked 
to the activity of the atypical PKC variant, PKMζ (Zhang et al., 2012; Khodorova et al., 2013, 
2017).  To determine whether this increased excitability was produced by protein synthesis, 
inhibitors of transcription or translation were used.  As illustrated in Fig. 1A, in either untreated 
or vehicle-treated isolated sensory neurons (combined data), exposure to 100 ng/ml NGF 
produced a significant time-dependent increase in the number of action potentials (APs) evoked 
by a depolarizing ramp of current (df=9, ss=402.9, n=10, P≤0.001).  The untreated and vehicle-
treated groups have been combined into a single control group since the effects of NGF were 
not different (Mann Whitney U(4,6)=14.0, n=10, P≥0.76).  In this combined data, there were no 
differences between the 6, 10, and 20 min treatments with NGF.  In a separate series of 
experiments, a 30 min pretreatment with 10 μM actinomycin-D, an inhibitor of transcription 
(Kersten et al., 1960; Goldberg et al., 1962), failed to alter the capacity of NGF to increase 
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neuronal excitability (Fig. 1B, H=19.2, df=5, n=7-9, P≤0.05), producing a sensitization of AP 
firing that was similar to that found in untreated/vehicle-treated neurons.  There were no 
differences between the 6, 10, and 20 min treatments with NGF.  By contrast, pretreatment with 
inhibitors of translation, either 60 μM cycloheximide (30 min, panel C, df=6, ss=17.5, n=7, 
P=0.07) or 500 nM rapamycin (60 min, panel D, df=7, ss=62.6, n=8, P=0.12), blocked the 
increase in excitability produced by NGF.  To corroborate the intended effects of rapamycin and 
cycloheximide, as they are known to have other potential effects, the small molecule inhibitor 
4EGI-1 was used.  This agent specifically blocks the interaction between the factors eIF4E and 
eIF4G and thereby inhibits cap-dependent translation; in Jurkat cells the IC50 for this blockage 
was 25-50 μM (Moerke et al., 2007).  As shown in Fig. 3E, a 30 min pretreatment with 30 μM 
4EGI-1 blocked the NGF-induced increase in excitability (df=6, ss=36.3, n=7, P=0.35).   
 
A recent report demonstrated that high-frequency stimulation of the CA3 Schaffer collateral-CA1 
synapse in hippocampal slices produced a rapid dephosphorylation of serine 406 in eIF4B.  This 
dephosphorylation was associated with increased levels of PKMζ protein; both the 
dephosphorylation and the increased protein were sensitive to okadaic acid, an inhibitor of 
protein phosphatase 1 and 2A (Eom et al., 2014).  Based on this finding, we measured the 
effects of okadaic acid on the capacity of NGF to enhance the excitability of sensory neurons.  
As shown in Fig. 1F, a 30 min pretreatment with 1 μM okadaic acid completely blocked the 
increase in AP firing produced by NGF (df=4, ss=3.1, n=7-9, P=0.75).  In parallel recordings 
from sensory neurons isolated in the same tissue harvests, NGF significantly increased AP 
firing by about 3-fold (control 3.2 ± 0.2 APs vs. 10 min NGF 9.6 ± 0.7 APs, df=4, ss=5.3, n=5, 
P≤0.001, data not shown).  These results are consistent with the observations in hippocampal 
slices.  Collectively, these results demonstrate that the ability of NGF to augment the firing of 
APs in sensory neurons depends on translational but not transcriptional activity. 
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NGF augments the levels of PKMζ protein 
The above results indicate that the sensitization produced by NGF requires protein synthesis.  
Such a finding raises the question as to whether this results in increased levels of PKMζ protein.  
Western blotting and densitometry of extracts from isolated sensory neurons were used to 
measure the changes in PKMζ protein in the absence or presence of NGF.  We previously 
identified a band at ~49 kDa as PKMζ (Zhang et al., 2012) and this molecular weight is similar 
to that reported for PKMζ by Sacktor’s laboratory (Sacktor et al., 1993; Hernandez et al., 2003).  
Film exposures of 1 s yielded measurable bands for the other isoforms of atypical PKCs, 
however this failed to yield a detectable band for PKMζ (data not shown).  Therefore, longer 
exposures were used (typically 20-30 s) to assess the levels of PKMζ.  A representative 
Western blot using the longer exposure time (see Fig. 2A) demonstrates that a 30 min treatment 
with 100 ng/ml NGF increased the density of the band at ~49 kDa.  This finding is consistent 
with the electrophysiological results reported above.  Pretreatment for 60 min with 50 μg/ml (178 
μM) cycloheximide, an inhibitor of the elongation phase of translation, reduced the amount of 
PKMζ protein (lane CHX+ NGF+) compared to NGF alone (lane CHX− NGF+).  The results from 
three separate Western blots are summarized in Fig. 2B wherein the measured density values 
were normalized to the values of their respective untreated controls.  A 30 min exposure to 100 
ng/ml NGF produced a significant increase (1.86 ± 0.30 fold, df=2, ss=0.5, n=3 tissue harvests, 
P≤0.05) in the amount of PKMζ protein compared to the untreated controls.  Treatment with 
cycloheximide blocked the NGF-induced increase wherein the measured values for PKMζ 
protein were reduced to 1.30 ± 0.26.  Cycloheximide by itself had no effect on the levels of 
PKMζ.  Our previous work demonstrated that full length PKCζ and PKCλ/ι proteins have 
molecular weights of approximately 75 and 62 kDa, respectively (Zhang et al., 2012).   Although 
PKMζ could not be detected at the 1 s exposures, band densities of the other atypical PKCs 
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were measured.  In the current studies, NGF had no significant effect on the expression levels 
of PKCζ (1.39 ± 0.16 normalized to their respective untreated controls 1.0, df=2, ss=0.3, n=3 
tissue harvests, P=0.12) or PKCλ/ι (1.19 ± 0.11, H=5.2, df=2, n=3 tissue harvests, P=0.16).  
Thus, these results indicate that NGF selectively increases the translational expression of PKMζ 
in isolated sensory neurons and that this increase is blocked by the protein synthesis inhibitor 
cycloheximide. 
 
Translation inhibitors block the NGF-induced mechanical hypersensitivity 
The systemic injection of NGF (Lewin et al., 1993) or its intraplantar injection into the hindpaw of 
a rat produces a hypersensitivity to both thermal and mechanical stimulation (Woolf et al., 1994; 
Andreev et al., 1995, respectively).  Our previous studies demonstrated that pretreatment with a 
blocking antibody to the p75 neurotrophin receptor prevented the NGF-induced increase in 
neuronal excitability (Zhang and Nicol, 2004) as well as the mechanical hypersensitivity 
resulting from the intraplantar injection of either NGF or proNGF (Khodorova et al., 2013).  
These results indicate that NGF can enhance neuronal sensitivity in vivo, an effect that may 
depend on translational control.  To explore this possibility, the inhibitors of translation, 
cycloheximide or rapamycin, were injected into the intraplantar surface of the rat’s hindpaw prior 
to the injection of NGF.  As illustrated in Fig. 3, both cycloheximide and rapamycin delayed the 
development of NGF-induced mechanical hypersensitivity.  (There being no difference among 
the baseline, pre-injection Response Efficiency in the 3 treatment groups (H=0.72, df=2, 
P=0.70), these were merged to give a single baseline value; n=29).  In vehicle control animals 
(n=6), where DMSO was injected 0.5 h before NGF (500 ng/10 μl), a significant increase in the 
responsiveness to the 15 g force over the baseline values (n=29) was detected at all test times 
after NGF (H=27.5, df=4, P≤0.0001); at 0.5 h  P=0.006, at 1 h P=0.006, at 3.5 h P=0.001, and at 
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22 h P=0.001.  In the untreated control animals, the single injection of 500 ng of NGF induced a 
mechanical hypersensitivity that slowly declined between days 1 and 4, and achieved a full 
recovery on day 5 (data not shown).  Injection of the vehicle alone, whether it be aqueous buffer 
(PBS) or DMSO, had no effect on paw responsiveness over one day, in the current experiments 
(data not shown), and in many previously published studies (e.g., Khodorova et al., 2013).   
 
In contrast to the robust increase in R.E. for the vehicle control group, for  the group where 
cycloheximide was injected 1 h before and then co-injected with NGF (total dose 200 nmol/paw, 
each injection 10 mM, n=11), the increase in mechanical sensitivity (H=17.7, df=4, P=0.001) 
was blocked at both 0.5 h (P=0.98 vs. baseline, n=29) and 1 h (P=0.82 vs. baseline) but was 
significant at 3.5 h (P=0.03 vs. baseline) and 22 h (P=0.0002) after NGF.  Similarly, when 
rapamycin (100 nmol/paw, n=12) was injected 0.5 h prior to NGF (H=22.01, df=4, P=0.0002),  
no significant increase in mechanical sensitivity occurred at 0.5 h (P=0.41), 1 h (P=0.08), or 3.5 
h (P=0.16, all vs. baseline, n=29).  In a parallel analysis, comparing the responses at each time 
between the vehicle control group and the two different Inhibitor treatment groups, at baseline 
there was no difference (as noted above).  At 0.5 h, (H=10.31, df=2, P=0.006); cycloheximide 
(n=11) vs. vehicle (n=6), P=0.006; rapamycin (n=12) vs. vehicle (n=6), P=0.005. At 1 h, 
(H=6.52, df=2, P=0.039), cycloheximide vs. vehicle P=0.02, rapamycin vs. vehicle P=0.04. For 
both cycloheximide and rapamycin treatments, the mechanical sensitivities had reached the 
vehicle control values when measured at 22 h (H=0.70, df=2, P=0.70), for cycloheximide vs. 
vehicle P=0.46 and for rapamycin vs. vehicle P=0.49).  These results demonstrate that inhibition 
of translation can delay the increase in mechanical sensitivity produced by NGF, although the 
suppressive effects are short-lived.  The time course of this suppression may depend on the 
metabolic stability of these compounds.  For example, in an in vitro study, the half-life of 
rapamycin in rat plasma was approximately 2.2 h (Ferron and Jusko, 1998). 
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Inhibitors of translation or atypical PKCs reverse the sustained hypersensitivity produced by 
NGF 
Intraplantar injection of higher doses of NGF (1-5 μg) produced a mechanical hypersensitivity 
that persisted for at least 4 days after the initial injection.  As shown in Fig. 4A, injection of NGF 
(4 μg/20 μl) produced a sustained hypersensitivity to the 15 g VFH stimulus over this period, 
with a slight fade of effect on D5 48 h after DMSO vehicle injection (H=26.9, df=5, n=8, 
P≤0.0001).  There were no significant differences in the levels of NGF-induced mechanical 
hypersensitivity between the 1, 3, and 4 μg/20 μl injections (a Χ
2
 analysis comparing the REs 
from these three doses of NGF at D3 (72 h) gave P=0.543); therefore, these results have been 
combined in Fig. 4A.  With this same protocol for producing sustained mechanical 
hypersensitivity, another group of rats (n=9) received a single injection of rapamycin (10 mM, 10 
μl) 3 days after an injection of 4 μg NGF (for all test times in this group H=25.8, df=5, P≤0.001).  
Mechanical hypersensitivity was reduced at 24 h after rapamycin compared to the value one 
day previously (P=0.01, D4 vs. D3, 4 h after rapamycin).  The rapamycin-diminished response, 
at 24h, was still above the pre-NGF baseline value (P=0.01), showing that a complete reversal 
of NGF-induced hypersensitivity was not achieved with this dose of rapamycin.  Furthermore, 
the response had not changed at 1.5 h after rapamycin (P=0.53 vs. D3, before rapamycin) nor 
at 4.5 h after rapamycin (P=0.07 vs. D3, before rapamycin); it appears that the effects of the 
inhibitor were not significant over the first 4 h after its injection, but were so by 1 day.  By 48 h 
after rapamycin (D5), mechanical sensitivity had returned to its pre-rapamycin level (see Fig. 
4B, P=0.20, D5 vs. D3 before rapamycin). 
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These changes in mechanical hypersensitivity after the injection of rapamycin were then 
normalized to their maximal possible effect (MPE), measured at D3 (see Procedures section for 
details).  As shown in Fig. 4C, at 24 h after the injection of rapamycin there was a significant 
reduction (approximately 40% MPE)  in normalized  hypersensitivity (H=12.2, df=2, P=0.002 for 
all 3 times, P=0.002 for D4 24 h vs. D3, 4 h after rapamycin, all n=9).  By 48 h (D5) after 
rapamycin the mechanical hypersensitivity had returned to the value measured at D3 (P=0.57).  
Although these effects were transient, the results suggest that continued mRNA translation is 
important in maintaining the hypersensitivity after exposure to NGF. 
 
We previously showed that treatment with mPSI, an inhibitor of the atypical PKCs, prevented 
the development of both the NGF-induced increase in neuronal excitability in vitro  (Zhang et al., 
2012) and the mechano-hypersensitivity in vivo (Khodorova et al., 2013).  These findings raise 
the question of whether exposure to mPSI could reduce mechano-hypersensitivity during the 
sustained period after higher NGF.  Following a similar protocol as described above for tests of 
rapamycin on sustained NGF-induced mechanical hypersensitivity, we found that intraplantar 
injection of mPSI on D3 (40 μg) after NGF resulted in a transient reduction in R.E. (H=18.4, 
df=4, P=0.001), with a significant decrease in the hypersensitivity measured 24 h later (n=11, 
P=0.016, D3 vs. D4), falling to levels that were not different from baseline (n=11, P=0.10) (see 
Fig. 5A).  Like the findings for rapamycin, the sensitivity returned to the pre-mPSI values 24 h 
later (P=0.73, D5 vs, D3).  In contrast, injection of the same dose of a scrambled analogue of 
mPSI (scr-mPSI) that has no inhibitory effect on aPKCs, had no effect at D4 (P=0.65, D4 vs. 
D3; Fig. 5A).  After scr-mPSI, responsiveness remained significantly above baseline for the next 
3 days (H=25.5, df=4, P≤0.0001) (Fig. 5A).  These results were then normalized by comparing 
the responsiveness after injected substances to the hypersensitivity measured at D3, before 
substance injection but after NGF, in each respective animal.  As shown in Fig. 5B, mPSI 
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caused a significant drop in the normalized %MPE responsiveness (H=7.8, df=2, P=0.02).  At 
24 h after the injection of mPSI the hypersensitivity was significantly reduced, by ~66% of the 
MPE (P=0.005), whereas after the injection of scr-mPSI there was no change in the 
hypersensitivity relative to D3 (P=0.31).  At 48 h (D5) after inhibitor injection, the mechanical 
hypersensitivities for those rats receiving the mPSI injection returned to their pre-injection 
values (P=0.73).  Taken together, these findings demonstrate that the NGF-induced mechanical 
hypersensitivity in vivo can be delayed by pretreatment with rapamycin or cycloheximide and 
that established hypersensitivity can be transiently reversed by either rapamycin or mPSI.  
These results indicate that translational synthesis in the periphery plays a critical role in 
generating as well as maintaining the heightened mechanical sensitivity produced by NGF, and 
suggest that PKMζ is a likely candidate for the synthesized critical mediator.  
 
DISCUSSION 
In this report we demonstrate that synthesis of a signaling protein is essential for the acute 
mechanical hypersensitivity caused by NGF, and for the changes in sensory neuron excitability 
that underlay that hypersensitivity.  Similarly, the protein levels of PKMζ in vitro were elevated 
after NGF treatment, which was blocked by pretreatment with an inhibitor of translation, 
cycloheximide.  The enhanced AP firing that resulted after NGF exposure was also blocked by 
inhibitors of translation, but not by an inhibitor of transcription.  Intraplantar injection of NGF 
produced a rapid increase in the local mechanical sensitivity that was maintained for 4-5 days.  
The onset of this NGF-induced hypersensitivity was delayed by pretreatment with either 
rapamycin or cycloheximide.  Interestingly, the maintained mechanical hypersensitivity could be 
transiently reversed by injection of either rapamycin or an inhibitor (mPSI) of atypical PKCs.  
Although our results indicate that NGF leads to the persistent on-going synthesis of a mediator 
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that promotes hypersensitivity (which we believe to be PKMζ), the transient action of the 
translation inhibitors might suggest that the half-life or stability of this mediator is limited, 
whereas the coding mRNA is present before NGF stimulation and then becomes persistently 
active.  Thus, the in vitro results demonstrate that NGF produces a rapid increase in the 
translational synthesis of PKMζ.  Elevated levels of this atypical PKC result in the enhanced AP 
firing of isolated small diameter sensory neurons as well as the heightened mechanical 
sensitivity of the hindpaw.  These observations would suggest that NGF when applied to either 
the neuronal cell bodies or the distal terminals of sensory (nociceptive) afferents leads to the 
acute translation of PKMζ.   
 
As noted above, the NGF-mediated in vivo mechanical sensitivity is significantly increased after 
just 30 min of exposure.  Changes in mechanical sensitivity in this amount of time are much too 
rapid to be accounted for by the retrograde transport of an NGF-induced signal back to the 
DRG.  Consistent with this idea, Stoeckel et al. (1975) showed that upon injection of 
125
I-NGF 
into the forepaw of a rat, it took at least 6 h to detect a significant increase in labeled NGF in the 
cervical (C6/7) DRG.  Maximal levels were attained between 11 and 16 h.  Therefore, these 
results for the slow retrograde movement of NGF to the DRG are incompatible with the rapid 
increase in mechanical hypersensitivity observed in our study.  Thus, the rapid enhancement of 
mechanical sensitivity is consistent with the idea of localized translation in those mechano-
sensitive fibers innervating the hind paw skin. 
 
The key findings of this study are also consistent with our previous studies.  In isolated sensory 
neurons, pretreatment with mPSI, but not bisindolylmaleimide I (an inhibitor of conventional and 
novel PKC isoforms), completely blocked the NGF-induced increase in evoked AP firing, 
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suggesting that an atypical PKC played a key role in augmenting the excitability (Zhang et al., 
2012).  Treatment with siRNAs targeted to the atypical PKCs decreased both the mRNA and 
protein levels for the PKMζ subtype, but not the full length PKCζ or PKCλ/ι isoforms of the 
atypical PKCs.  Functionally, these siRNAs also blocked the enhanced AP firing produced by 
NGF.  Internal perfusion of neurons with either recombinant PKCζ or PKCλ/ι via the recording 
pipette produced a significant increase in AP firing, which likely results from the high degree of 
homology in the catalytic domains for the atypical PKCs.  In support of these in vitro findings, 
pre-injection of mPSI into the intraplantar surface significantly reduced the mechanical 
hypersensitivity resulting from a subsequent intraplantar injection of NGF (Khodorova et al., 
2013). 
 
PKMζ may play a causal role in regulating the level of neuronal sensitivity.  Previous studies 
have used the pseudosubstrate inhibitor to explore the role of the atypical PKCs.  It is important 
to note that this pseudosubstrate inhibitor (sometimes referred to as ZIP, zeta inhibitory peptide) 
lacks the selectivity to discriminate between the different isoforms of the atypical PKCs because 
of the high degree of homology in the pseudosubstrate domain (Selbie et al., 1993; Akimoto et 
al., 1994; Hirai and Chida, 2003).  Using an interleukin-6-induced model of persistent 
sensitization, Asiedu et al. (2011) showed that intrathecal injection of ZIP greatly accelerated 
the recovery of the resulting mechanical allodynia for both the acute IL-6-mediated allodynia as 
well as the long-lasting allodynia produced by PGE2.  To further examine the role of atypical 
PKCs in promoting this persistent sensitization, a lenti-viral expression of a constitutively active 
form of PKCζ in the dorsal horn of the spinal cord produced a sensitization that lasted for 
approximately 6 days (Asiedu et al., 2011).  Two additional studies demonstrated that 
intrathecal injection of ZIP suppressed the second phase of the pain response evoked by 
intraplantar injection of formalin (Marchand et al., 2011; Laferrière et al., 2011).  These results 
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indicate that an atypical PKC (although the specific isoform was not resolved) plays a critical 
role in the heightened sensitivity that results from a variety of inflammatory insults.  However, 
since substances injected intrathecally can diffuse down the spinal roots to the DRG as well as 
enter the spinal cord, it is unclear if the critical atypical PKC is expressed in primary afferents or 
in spinal neurons (or glia). 
 
Prior studies established that a long-lasting form of synaptic plasticity depends on the synthesis 
of new protein (late-phase long-term potentiation, L-LTP)(reviewed in Kelleher et al., 2004; 
Costa-Mattioli et al., 2009).  In addition, L-LTP can be produced by exposure to a variety of 
agonists, in particular, brain-derived neurotrophic factor (BDNF).  In recordings from the 
Schaffer collaterall-CA1 pyramidal cell synapse of the adult rat hippocampus, exposure to 
BDNF elicited a dramatic increase in synaptic transmission/strength that was blocked by 
translational inhibitors, such as cycloheximide or rapamycin (Kang and Schuman, 1996; Tang et 
al., 2002).  In cortical neurons isolated from E18/19 rat embryos, exposure to BDNF generated 
a rapid increase (within 30 min) in protein synthesis as measured by the incorporation of 35S-
methionine (Takei et al., 2001), which was blocked by treatment with either the PI3K inhibitor 
LY249002 or rapamycin, but not the transcriptional inhibitor actinomycin D.  These 
pharmacological results are similar to our previous findings that demonstrated that the NGF-
induced sensitization of AP firing was prevented by the inhibitor of PI3K, but not that of MEK 
(Zhang et al., 2012), which suggested that a NGF-PI3K pathway is essential for enhancing 
neuronal excitability.  Taken together with our current observations, these results would indicate 
that NGF augments neuronal excitability through a PI3K-mediated pathway that depends on the 
translation of newly synthesized protein. 
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Earlier reports indicated that translation plays a key role in regulating the extent of the pain 
response after either inflammatory insults or neuropathic nerve injury.  The formalin test is a 
commonly used model of inflammatory pain wherein the secondary response, which is believed 
to be mediated by sensitization of nociceptive spinal cord pathways, was suppressed in a dose-
dependent manner by intraperitoneal injection of cycloheximide (Hou et al., 1997).  Later studies 
showed that application of rapamycin by either intrathecal or intraplantar injection also 
suppressed this secondary response, implying important regulation by the mTOR pathway 
(Price et al., 2007).  In addition, components of the mTOR pathway were localized to A-type 
nerve fibers found in the skin, many of which co-expressed N52, a marker for myelinated fibers 
(Jiménez-Díaz et al., 2008); in electromyographic recordings these same authors reported that 
rapamycin suppressed the secondary mechanical hyperalgesia (thought to be mediated by A-
type fibers) resulting from the cutaneous injection of capsaicin.  In vivo electrophysiological 
recordings from wide dynamic range spinal neurons showed that increased neuronal activity 
associated with the secondary response to formalin was blocked by pretreatment with 
rapamycin (Asante et al., 2009).  This same group detected phosphorylated S6 kinase, a key 
kinase in mTOR-mediated translation, in the dorsal root ganglia (Asante et al., 2010).  In 
support of our findings, NGF exposure (15 min duration) of dorsal root ganglia neurons isolated 
from adult mice resulted in the phosphorylation of serine-2448 of mTOR, 4EBP, eIF4E, eIF4G, 
and AKT (Melemedjian et al., 2010).  Together, IL-6 and NGF resulted in increased protein 
synthesis that was blocked by a 30 min pretreatment with 500 nM rapamycin or the inhibitor of 
eIF4F complex formation, 4EGI-1 (Melemedjian et al., 2010).    
 
In neurons, a key tenet of activity-dependent modulation of translation is that the specific 
mRNAs are properly localized in the dendritic fields.  Using in situ hybridization, the mRNA for 
PKMζ was localized in both the cell bodies and the dendrites of hippocampal and sympathetic 
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neurons grown in culture (Muslimov et al., 2004); these authors found that two targeting 
elements were required to traffic PKMζ mRNA to the dendritic compartment.  Interestingly, BC1 
RNA, a repressor of translation initiation, can become co-localized with PKMζ mRNA, 
suggesting that there are trans-acting factors that can modulate localization of the PKMζ 
transcript.  In addition, it was suggested that heterogeneous nuclear ribonucleoprotein A2 
(hnRNP A2) also plays a key role since an antisense oligonucleotide targeted to hnRNP A2 
significantly reduced the amount of PKMζ mRNA delivery to the neuronal dendrites (Muslimov 
et al., 2011).  Recent work demonstrated that the ability of BC1 RNA to repress translation 
depends on the phosphorylation state of serine 406 of eIF4B (Eom et al., 2014).  In 
hippocampal slices, high-frequency stimulation of the CA3 Schaffer collateral-CA1 synapse 
resulted in a rapid dephosphorylation of serine 406 in eIF4B that was associated with increased 
levels of PKMζ protein; both events were sensitive to okadaic acid (Eom et al., 2014).  These 
findings suggest that that phosphorylation of eIF4B represses translation whereas 
dephosphorylation of this serine initiates translation, leading to an “on-demand” synthesis of key 
neuronal proteins.  It is unknown whether this type of translational control is involved in the 
sensitization of sensory neurons resulting from exposure to pro-inflammatory mediators, such 
as NGF. 
 
Conclusions 
We demonstrate that NGF leads to the synthesis of the atypical PKC, PKMζ, and that this 
molecule plays a critical role in regulating the excitability of isolated sensory neurons as well as 
the behavioral sensitivity to mechanical stimulation.  The maintained mechanical 
hypersensitivity produced by NGF could be transiently reversed by inhibition of either translation 
or atypical PKCs.  These findings suggest that the ongoing translational synthesis of PKMζ 
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plays a critical role in the generation as well as the maintenance of the heightened mechano-
sensitivity produced by NGF.   
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Figure Legends 
Figure 1.  NGF produces sensitization of isolated sensory neurons that is blocked by inhibitors 
of translation, but not transcription.  Panel A. Treatment with 100 ng/ml NGF significantly 
increases the number of evoked APs in either untreated sensory neurons or in neurons exposed 
to the vehicle DMSO alone.  Asterisks represent a significant difference between the control and 
those treated with NGF.  The ordinate and axis labels in A apply to panels B, C, D, and E.  
Panel B.  A 30 min pretreatment with 10 μM actinomycin D (a transcription inhibitor) does not 
affect the sensitization produced by NGF.  Asterisks represent a significant difference between 
the control and those treated with NGF.  Panel C. A 30 min pretreatment with 60 μM 
cycloheximide (a translation inhibitor) blocks the sensitization produced by NGF.  Panel D.  A 60 
min pretreatment with 500 nM rapamycin (a translation inhibitor) blocks the sensitization 
produced by NGF.  Panel E.  A 30 min pretreatment with 30 μM 4EGI-1 (a translation inhibitor) 
blocks the sensitization produced by NGF.  Panel F.  A 30 min pretreatment with 1 μM okadaic 
acid (an inhibitor of protein phosphatase 1/2A) blocked the sensitization produced by NGF.   
 
Figure 2.  NGF significantly increases the amount of PKMζ, protein, which is blocked by 
cycloheximide.  Panel A illustrates a representative Western blot wherein exposure to 100 ng/ml 
NGF for 30 min increases the level of PKMζ protein (the 49 kDa band).  In contrast, no NGF–
induced increase in PKMζ occurs after pretreatment with 50 μg/ml cycloheximide for 1 h.  The 
bottom panel indicates the amounts of HPRT protein as a loading control.  Panel B summarizes 
the results obtained from three different Western blots obtained from three different tissue 
harvests.  Exposure to 100 ng/ml NGF for 30 min significantly increased the amount of PKMζ 
protein normalized to their respective HPRT levels.  The amounts of PKMζ after these different 
treatments were then normalized to their corresponding levels of PKMζ protein obtained for the 
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untreated condition (-NGF, -CHX) (data not shown).  The asterisk represents a significant 
difference between the NGF+ CHX− and all other samples. 
 
Figure 3.  NGF produces mechanical hyperalgesia that is suppressed by either cycloheximide or 
rapamycin.  Response Efficiency after NGF when paw is pre-treated by Vehicle (Veh), 
Cycloheximide (CHX) or Rapamycin (Rapa).  When compared to the (merged) baseline value, 
responses to NGF (all for 15g VFH)  after Vehicle injections (n= 6) are significantly different at 
0.5, 1, 3.5 and 22 h, whereas those after CHX (n=11) or Rapa (n=12) only reach significance at 
22 h (*** P≤0.005, ** P≤0.01, Kruskal-Wallis, Wilcoxon Rank sum tests).  In comparison to the 
Responses after Vehicle, those after CHX or Rapa are significantly different at 0.5, 1 and 3.5 h 
(### P≤0.005, ## P≤0.01, # P≤0.05, Kruskal-Wallis/Wilcoxon Rank Sum tests).   
 
Figure 4.  Established NGF-induced mechanical hyperalgesia is transiently reversed by local 
injection of rapamycin.  Panel A: local injection of the vehicle, DMSO, did not affect the pre-
existing NGF-induced hypersensitivity, measured acutely or 24 h and 48 h after DMSO injection 
(n=8).  Friedman’s test for 6 groups comparing the baseline values with the responses at other 
time points: P=0.0004, *P≤0.05, **P≤0.01 vs. baseline with Dunn’s post hoc pair-wise test.  
Panel B: the NGF-induced hypersensitivity was significantly reduced 24 h after the injection of 
rapamycin (10 mM; 10 μl) on D3 (n=9).  Established hypersensitivity shown by Friedman’s test 
for 6 groups comparing baseline value with the responses at other time points: P≤0.0001, then  
*P≤0.05, **P≤0.01, ***P≤0.001 vs. baseline (Dunn’s post hoc pair-wise test). Effect of rapamycin 
shown by comparing the D4 (24 h of rapamycin) value vs. the 4 h D3 value or the D3 value 
before rapamycin, ##P≤0.005, two-tailed Wilcoxon test  Panel C: Injection of rapamycin 
produces a significant decrease (at D4), 24 h after rapamycin injection, in the maximal possible 
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hypersensitivity produced by NGF, as measured at D3 (% MPE) (P=0.002, Kruskal-Wallis test, 
**P≤0.01 vs. the 4 h D3 value and *P≤0.05 vs.48 h D5 value, Dunn’s post hoc pair-wise test). 
 
Figure 5.  Established NGF-induced mechanical hyperalgesia is transiently reversed by local 
injection of mPSI.  Panel A: Hindpaw injection of NGF (1 μg/10 μl) produced a significant 
increase in mechanical sensitivity on D3 (n=3), at which time mPSI (40 μg/20 μl) was injected 
into the same hindpaw.  Measurements on D4 showed a reversal of the mechanical 
hypersensitivity back towards the baseline response value.  These three data sets for each rat 
(n=3 rats), were taken at 24, 48 and 72 h after mPSI, respectively, and were then compared by 
Friedman’s test, which showed a significant difference among all three with P=0.0015.  
Application of Dunn’s test post-hoc for pair-wise comparison showed that D4 (24 h) and D5 (48 
h) values differed significantly, **P≤0.01, but none of the other pairs were different.  Panel B: 
Injection of mPSI produces a significant decrease in the percentage of the maximal possible 
hypersensitivity produced by NGF relative to that measured at D3 (%MPE).  Rats receiving a 
local injection of scrambled mPSI (40 μg/20 μl, n=3) exhibited no significant change in 
mechanical sensitivity on D4 and D5.  Friedman’s test for 3 groups comparing value at 24 h with 
the responses at other time points: P=0.0015, **P≤0.01 vs. 48 h after mPSI (Dunn’s post hoc 
test).   
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